$RGEN 5 year climb $41.63 called 7/13/14 $24.1
Post# of 63700
called 7/13/14 $24.10
Nasdaq GM
Website
Repligen Corporation, a life sciences company, develops,
manufactures, and markets consumable bioprocessing products
for use in the production of monoclonal antibodies and other
biologic drugs. The company manufactures various forms of Protein A,
a critical reagent used in biomanufacturing to separate and purify
monoclonal antibodies
Shares Outstanding: 32.85M
Float: 31.98M
% Held by Insiders: 6.20%
% Held by Institutions: 85.40%
Shares Short (as of Apr 15, 2015): 3.47M
Short Ratio (as of Apr 15, 2015): 7.40
Short % of Float (as of Apr 15, 2015 :12.10%
Shares Short (prior month): 3.64M
Headlines